A Pilot Genome-Wide Association Study in Postmenopausal Mexican-Mestizo Women Implicates the RMND1/CCDC170 Locus Is Associated with Bone Mineral Density.
Marisela Villalobos-ComparánRogelio F Jiménez-OrtegaKarol EstradaAlma Y Parra-TorresAnahí González-MercadoNelly PatiñoManuel Castillejos-LópezManuel QuiterioJuan Carlos Fernandez-LópezBertha IbarraSandra Romero-HidalgoJorge SalmerónRafael Velázquez-CruzPublished in: International journal of genomics (2017)
To identify genetic variants influencing bone mineral density (BMD) in the Mexican-Mestizo population, we performed a GWAS for femoral neck (FN) and lumbar spine (LS) in Mexican-Mestizo postmenopausal women. In the discovery sample, 300,000 SNPs were genotyped in a cohort of 411 postmenopausal women and seven SNPs were analyzed in the replication cohort (n = 420). The combined results of a meta-analysis from the discovery and replication samples identified two loci, RMND1 (rs6904364, P = 2.77 × 10-4) and CCDC170 (rs17081341, P = 1.62 × 10-5), associated with FN BMD. We also compared our results with those of the Genetic Factors for Osteoporosis (GEFOS) Consortium meta-analysis. The comparison revealed two loci previously reported in the GEFOS meta-analysis: SOX6 (rs7128738) and PKDCC (rs11887431) associated with FN and LS BMD, respectively, in our study population. Interestingly, rs17081341 rare in Caucasians (minor allele frequency < 0.03) was found in high frequency in our population, which suggests that this association could be specific to non-Caucasian populations. In conclusion, the first pilot Mexican GWA study of BMD confirmed previously identified loci and also demonstrated the importance of studying variability in diverse populations and/or specific populations.
Keyphrases
- bone mineral density
- postmenopausal women
- genome wide association study
- genome wide
- high frequency
- systematic review
- body composition
- genome wide association
- small molecule
- meta analyses
- transcranial magnetic stimulation
- clinical trial
- gene expression
- transcription factor
- high throughput
- polycystic ovary syndrome
- single cell
- study protocol
- clinical evaluation